Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Timely diagnosis and treatment of aortic stenosis improved modestly from 2023 to 2024 but remain suboptimal, with only 54-61% diagnosed within 30 days at a national level.

• Why it matters: Delayed diagnosis and treatment of aortic stenosis increase patient mortality, highlighting the need for better quality measures and standardized care processes across healthcare systems.
• What they did: The AHA Target: AS registry analyzed data from 8,097 patients across 58 sites, focusing on key quality metrics such as diagnosis within 30 days and treatment within 90 days, along with echocardiogram documentation and multidisciplinary evaluation.
• The result: While some improvements were observed, significant gaps persist in timely symptom assessment, multimodality testing, and surveillance echocardiograms, underscoring opportunities to enhance care quality and patient outcomes through targeted interventions.